Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis.

Antimicrob Agents Chemother · 2019 · PMC6496099 · PMID 30833432

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Inclusion of PMD significantly reduced lung CFU counts over the first month of treatment and reduced the proportion of mice relapsing, although the effect of PMD on relapse did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.